应用诊断管理优化真菌聚合酶链反应:阴性结果后血浆与支气管肺泡灌洗液随访检测的收益低
这项回顾性单中心研究评估了血浆和支气管肺泡灌洗液真菌PCR首次阴性后1、2、3、4周随访检测的阳性率。共分析264例患者的406份血浆标本和431例患者的983份支气管肺泡灌洗液标本所对应的1389次随访检测。血浆随访阳性率分别为2.7%、3.3%、5.1%、3.5%,支气管肺泡灌洗液为0%、0.3%、0.4%、0.7%;作者结论为首次阴性后4周内随访检测收益低,首周内极少产生有临床意义的阳性结果。
要点
- 血浆真菌PCR首次阴性后1、2、3、4周随访阳性率依次为2.7%、3.3%、5.1%、3.5%
- 支气管肺泡灌洗液真菌PCR首次阴性后1、2、3、4周随访阳性率依次为0%、0.3%、0.4%、0.7%
- 阳转患者均为免疫功能受损者,首周内仅1例血浆第7天曲霉阳性被判为可能真菌病
核心结论
- 作者认为,首次真菌PCR阴性后4周内对血浆和支气管肺泡灌洗液进行随访检测收益低,首周内极少产生被认为有临床意义的阳性结果。
研究设计与样本
- 回顾性单中心研究,评估血浆和/或支气管肺泡灌洗液(BAL)真菌PCR首次阴性后1、2、3、4周随访检测的阳性收益。
- 共纳入1389次随访检测,对应264例患者的406份血浆标本和431例患者的983份BAL标本。
- 检测目标为曲霉属、毛霉目、镰刀菌属、足放线菌属、双相真菌、耶氏肺孢子菌和念珠菌属。
主要发现
- 血浆随访阳性率在1、2、3、4周分别为2.7%(4/148)、3.3%(4/123)、5.1%(4/78)、3.5%(2/57)。
- BAL随访阳性率在1、2、3、4周分别为0%(0/333)、0.3%(1/288)、0.4%(1/228)、0.7%(1/134)。
- 阳转涉及血浆曲霉属、毛霉目和镰刀菌属PCR,以及BAL曲霉属和耶氏肺孢子菌PCR;所有阳转患者均为免疫功能受损者。
- 前次阴性检测后1周内,血浆有2次曲霉和2次毛霉目PCR阳性,BAL无阳性检测。
- 第1周内仅1次曲霉属阳性(第7天阳性)被判为可能真菌病。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early diagnosis of invasive fungal disease is essential for optimizing management. Although the clinical utility of fungal polymerase chain reaction (PCR) testing on plasma and bronchoalveolar lavage (BAL) has been established, the role of follow-up testing remains unclear. METHODS: This was a retrospective single-center study. The yield of follow-up PCR for Aspergillus species, Mucorales agents, Fusarium species, Scedosporium species, dimorphic fungi, Pneumocystis jirovecii, and Candida species on plasma and/or BAL was measured at intervals of 1, 2, 3, and 4 weeks following a negative result. RESULTS: A total of 1389 follow-up tests on 406 plasma specimens from 264 patients and 983 BAL specimens from 431 patients were evaluated. Overall, the positivity rate at 1, 2, 3, and 4 weeks was 2.7% (4/148), 3.3% (4/123), 5.1% (4/78), and 3.5% (2/57), respectively, on plasma, and 0% (0/333), 0.3% (1/288), 0.4% (1/228), and 0.7% (1/134), respectively, on BAL. Conversions occurred with Aspergillus species, Mucorales agents, and Fusarium species PCR on plasma and Aspergillus species and P jirovecii PCR on BAL. All patients who converted were immunocompromised. Within 1 week of a prior negative test, 2 Aspergillus and 2 Mucorales PCRs were positive on plasma, and zero tests were positive on BAL. In week 1, only 1 Aspergillus species that was positive on day 7 was classified as probable fungal disease. CONCLUSIONS: Fungal PCR follow-up testing on plasma and BAL within 4 weeks of a prior negative result was of low yield and rarely generated a positive result considered clinically significant in the first week.
引用
- Wang T, Park B, Anderson G, et al. Application of Diagnostic Stewardship to Fungal Polymerase Chain Reaction: Low Yield of Follow-up Testing on Plasma and Bronchoalveolar Lavage After a Negative Result. Clin Infect Dis. 2024. PMID: 39162527. doi:10.1093/cid/ciae382
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。